Edgewise Therapeutics, Inc. (EWTX)

NASDAQ: EWTX · Real-Time Price · USD

43.18

-0.38 (-0.87%)

At close: Aug 13, 2026, 4:00 PM EDT

42.70

-0.48 (-1.11%)

Pre-market: Aug 14, 2026, 7:50 AM EDT

Edgewise Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	72.32	61.15	41.67	86.1	21.99	15.57
Short-Term Investments	388.39	468.96	428.5	232.3	329.95	265.22
Cash & Short-Term Investments	460.71	530.11	470.17	318.39	351.95	280.79
Cash Growth	-22.44%	12.75%	47.67%	-9.53%	25.34%	117.51%
Other Current Assets	6.45	13.28	5.31	8.6	5.05	2.98
Total Current Assets	471.52	543.39	475.48	327	357	283.77
Net Property, Plant & Equipment	8.17	9.22	11.07	12.69	9.85	0.91
Other Long-Term Assets	-	-	0.26	0.35	0.25	0.55
Total Assets	479.69	552.6	486.82	340.04	367.1	285.23
Accounts Payable	4.67	6.01	5.58	4.03	6.11	3.84
Accrued Expenses	13.77	20.35	17.29	11.77	9.87	6.68
Current Portion of Leases	1.02	1.01	1	0.98	0.61	-
Total Current Liabilities	29.04	27.37	23.86	16.77	16.59	10.52
Long-Term Leases	2.57	2.98	3.74	4.43	3.8	-
Other Long-Term Liabilities	-	-	-	-	-	0.33
Total Long-Term Liabilities	2.57	2.98	3.74	4.43	3.8	0.33
Total Liabilities	31.61	30.35	27.6	21.21	20.39	10.85
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-in Capital	1,101	1,068	837.36	563.49	492.67	351.85
Accumulated Other Comprehensive Income	-0.5	0.68	0.42	0.1	-1.36	-0.51
Retained Earnings	-652.71	-546.37	-378.58	-244.76	-144.6	-76.96
Total Common Shareholders' Equity	448.08	522.26	459.22	318.83	346.72	274.38
Shareholders' Equity	448.08	522.26	459.22	318.83	346.72	274.38
Total Liabilities & Equity	479.69	552.6	486.82	340.04	367.1	285.23
Total Debt	3.59	3.99	4.74	5.41	4.41	0
Net Cash (Debt)	457.12	526.12	465.43	312.98	347.54	280.79
Net Cash Growth	-22.47%	13.04%	48.71%	-9.94%	23.77%	117.51%
Net Cash Per Share	4.29	5.11	5.04	4.91	6.49	7.48
Book Value	448.08	522.26	459.22	318.83	346.72	274.38
Book Value Per Share	4.20	5.07	4.97	5.00	6.47	7.31
Tangible Book Value	448.08	522.26	459.22	318.83	346.72	274.38
Tangible Book Value Per Share	4.20	5.07	4.97	5.00	6.47	7.31

SEC Filings: 10-K · 10-Q